CTLA4 Expression in Childhood Asthma and the Effect of Treatment with Inhaled Corticosteroid and Leukotriene Receptor Antagonist
Journal Title: Annual Research & Review in Biology - Year 2016, Vol 10, Issue 2
Abstract
Aims: Cytotoxic T lymphocyte antigen 4 (CTLA4), an important regulatory molecule in the process of antigen presentation, was previously associated with the pathogenesis of autoimmune diseases and asthma. Therefore, the goal of our study was to determine the expression of CTLA4 in asthmatics, and the effect of CTLA4 CT60 genotype and antiasthmatic treatment on CTLA4 expression. Study Design: We analyzed a case-control cohort of 229 children with mild to moderate persistent asthma. Blood samples were collected before treatment from 229 asthmatics, with matching samples obtained 4-6 weeks after treatment with inhaled corticosteroid (ICS) in 69 subjects and after treatment with leukotriene receptor antagonist (LTRA) in 105 subjects. Place and Duration of Study: Department of Pediatric Medicine, General Hospital Murska Sobota and University Medical Centre Maribor between January 2008 and May 2012. Methodology: We measured and compared CTLA4 expression in blood leukocytes of healthy controls and children with persistent asthma by qPCR and determined CTLA4 CT60 genotype by High Resolution Melting analysis. We further analyzed how antiasthmatic treatment with ICS or LTRA affected CTLA4 expression. Results: Median relative expression of full length CTLA4 (flCTLA4) isoform in asthmatics was 0.440±0.425, compared to 1.000±0.738 in controls (corrected P<.0001), and of soluble CTLA4 (sCTLA4) isoform in asthmatics was 0.580±0.468 compared to 1.040±1.080 in controls (corrected P<.0001). After ICS therapy the median relative expression of sCTLA4 significantly increased only in asthmatics with A allele, from 0.400±0.258 to 0.710±0.608 (corrected P=.0146). On the other hand, after LTRA therapy the median relative expression of sCTLA4 decreased only in asthmatics with A allele from 0.450±0.410 to 0.300±0.300 (corrected P=0.0006). Conclusion: We show that CTLA4 expression is decreased in asthmatic subjects. ICS and LTRA treatments, dependent on CTLA4 CT60 genotype, caused opposite effects on sCTLA4 expression, suggesting both drugs differently affect molecular pathways of antigen presentation during their action.
Authors and Affiliations
Vojko Berce, Carina E. P. Kozmus, Uroš Potočnik
Keywords
Related Articles
- EP ID EP351084
- DOI 10.9734/ARRB/2016/24564
- Views 74
- Downloads 0
In vitro Propagation of Oreocallis grandiflora (Lam.) R. Br., A Medicinal Threatened Plant
Aims: To promote the conservation and biotechnology approach of Oreocallis grandiflora, a promising wild, medicinal and agroforestry Peruvian plant, a methodology for its in vitro propagation was performed. Study Design:...
A Taxonomic Revision of Genus Polygonum L. sensu lato (Polygonaceae) for Flora of Iran
The genus Polygonum L. sensu lato is revised based on articles, herbarium documents and field observations. In this article, a brief revision of this genus in Iran is presented. It was first described by Rechinger and Sc...
Radiation Pollution and Cancer Risks in Sulaimaniyah and Ninawa Cities, Iraq
Pollution is the entry of contaminants into the environment or ecosystem which causes adverse change. The severe cases of radiation contamination lead to changes in DNA leading to genetic mutation, as happened in Hiroshi...
Mean Variance Relationships of Genome Size and GC Content
The present article focuses how the genome size and GC content are explained based on codon and amino-acid usage. This current study aims to identify the statistically significant factors of genome size and GC content us...
Erythrocytes’ Microrheological Features of Piglets during the Phase of Dairy-vegetable Nutrition after Damage or Common Supercooling
Notwithstanding the great successes of biology and veterinary science, possible changes of cytoarchitecture and erythrocytes’ aggregation in piglets during the phase of dairy-vegetable nutrition after unfavorable environ...